REFERENCES
- Li LS, Guan TJ, Liu ZH, Zeng CH, Tang Z. Demographic investigation of glomerular diseases in Chinese adults. J Nephrol Dialy Transplant. 1997; 6(2)103–103
- Chen HP, Zeng CH, Hu WX, Tang Z, Liu ZH, Li LS. Analysis of 10594 renal biopsy data. J Nephrol Dialy Transplant. 2000; 9(6)501–508
- Tang Z, Li LS, Zhang JH, Yu YS, Wang QW, Jiang W. Clinical and pathological features in IgA nephropathy patients with crescentic formation. Chin J Nephrol. 1993; 9: 80–84
- Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001; 38: 588–596
- Ramos EL, Tisher CC. Recurrent diseases in the renal transplant. Am J Kidney Dis. 1994; 24(1)142–154
- Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001; 60: 1948–1954
- Floege J. Recurrent IgA nephropathy after renal transplantation. Sem Nephrology. 2004; 24(3)287–291
- Diaz-Tejeiro R, Maduell F, Diez J, et al. Loss or graft due to recurrent IgA nephropathy with rapidly progressive course: An unusual clinical evolution. Nephron 1990; 54: 341–344
- Streather CP, Scoble JE. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis. Nephron. 1994; 66: 113–114
- Kimata N, Tanabe K, Ishikawa N, et al. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc. 1996; 28: 1537–1539
- Kowalewska J, Yuan S, Sustento-Reodica N, et al. IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis. 2005; 45(1)167–175
- Churg J, Bernstein J, Glassock R. Renal Disease Classification and Atlas of Glomerular Diseases 2nd. Igaku-Shoin, New York 1995; 134–135
- Schwarz A, Kraus P-H, Offerman G, et al. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis. 1991; 17: 524–531
- Berger J, Yaneya H, Nabarra B, et al. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int. 1975; 7: 232–241
- Nowack R, Birck R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephritits. Lancet. 1997; 349: 774
- Allison AC, Eugui EM. Mycophenolate mofetil and its mechanism of action. Immunopharmacology. 2000; 47: 85–94
- Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP. A new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol. 1998; 9: 2055–2066
- Hu WX, Chen X, Yao XD, Tang Z, Liu ZH, Li LS. Clinical trial of mycophenolate mofetil therapy for renal lesions in patients with small vasculitis. J Nephrol Dialy Transplant. 2002; 11(2)110–115
- Chan TM, Li FK, Tang CS. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol. 2005; 16: 1078–1084
- Chen X, Chen P, Cai G. A randomized controlled trial of mycophenolate mofetial treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi. 2002; 82: 796–801